JETPHARMA
ActiveSummary
JETPHARMA has been active since 2012 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €14,285 and a net result of €22,181. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 29% of 22,632 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
History
Acts, filings and financial milestones
09-10
Gazette deed
Resignation: ENGELEN Dominique Berthe Jeanne (manager)Appointment: ENGELEN Dominique Berthe Jeanne (director) · Amendment of the articles · Capital conversion11 facts ▸
- General meeting, 21-09-2023
- Amendment of the articles (2 times)
- Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
- Reserve release, “fonds disponibles pour distribution, Deuxième résolution, suppression” (deed in French)
- Capital
- Other provision, “compte de capitaux propres statutairement indisponible, Article 6” (deed in French)
- Director resignation, ENGELEN Dominique Berthe Jeanne (manager)
- Director appointment, ENGELEN Dominique Berthe Jeanne (director (not named in the articles))
- Director discharge, ENGELEN Dominique Berthe Jeanne
- Registered office clause, “1090 Jette,Avenue de la Constitution 102” (deed in French)
- General meeting, “clôture, prises à l'unanimité des voix” (deed in French)
About the unread acts
Of the 3 Belgian Official Gazette deeds we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.